Iron

Urinary iron reflects iron leaving your body through your kidneys. The amount can change with systemic iron overload, kidney injury, certain treatments, and occupational exposure. It serves as a supporting measure during some iron-removal treatments, alongside ferritin and MRI of organ iron. Its value for preventive screening and predicting future disease remains exploratory.

This test measures total iron in a urine sample using ICP-MS, a sensitive metal-analysis method. The method detects iron across the chemical forms present in the sample. A spot sample describes the concentration at collection; measuring total daily loss requires a timed collection.

How Iron Ends Up in Urine

Transferrin carries iron in the liquid part of your blood. Some iron passes through the kidneys' filters, and cells lining the small kidney channels reclaim almost all of it. A small human study found increased urinary iron in people with systemic iron overload and in people whose kidney channels weren't reabsorbing substances normally. Only the overload group also had raised blood iron.

• More iron delivered: increased circulating iron can increase the amount available for filtration, even when the kidneys work normally.
• More passage through the filter: kidney damage that lets protein leak into urine can carry iron and iron-carrying proteins with it.
• Less reabsorption: damaged kidney cells can fail to recover iron that has already passed through the filter.

These routes can overlap. A urinary iron result alone cannot distinguish them or quantify the iron stored in your organs.

Kidney Damage and Survival After Transplant

A study followed 693 stable kidney transplant recipients for about five years. It measured iron concentration in pooled 24-hour urine, so its estimates shouldn't be applied directly to a single spot sample. Higher concentrations accompanied poorer kidney filtration, more urine protein, and other markers of kidney injury.

Higher urinary iron was associated with higher mortality during follow-up after adjustment for kidney function, urine protein, and other factors. The association with transplant failure was no longer statistically significant after accounting for urine protein.

Urinary iron wasn't associated with ferritin or transferrin saturation in this cohort. These findings support further study of kidney iron handling, but they don't establish that lowering urinary iron improves survival or that routine monitoring benefits transplant recipients.

Liver Injury

In a Chinese cohort of 4,220 adults, higher urinary iron was associated with higher ALT. ALT is an enzyme used to assess liver cell injury. Participants with persistently higher urinary iron also had a greater chance of developing raised ALT over three years. The study used ALT to flag possible liver injury; it did not establish a specific liver diagnosis.

Lipid peroxidation is chemical damage to fats in cell membranes. A statistical analysis estimated that a urinary marker of this process accounted for about 22.5% of the association between urinary iron and ALT levels. That percentage concerned the association with ALT, not the development of new liver injury. The analysis suggests a possible pathway but cannot establish that iron caused the liver changes.

Blood Pressure and Uric Acid

Studies of blood pressure point in different directions. Among 3,733 older adults in Yinchuan, China, higher urinary iron was associated with slightly lower odds of hypertension. A Wuhan study of 823 adults found the opposite: people in the top quarter of urinary iron had about 4.9 times the odds of hypertension of those in the bottom quarter. A case-control study of 502 people with hypertension and 502 without found the same upward trend.

Among 6,508 older adults in Shenzhen, lower urinary iron had a roughly linear association with raised blood uric acid, and low urinary iron combined with high urinary zinc carried higher odds. A separate Yinchuan analysis of 3,756 older adults found the same inverse link. Kidney filtration accounted for about 11% of it, so part of the pattern may reflect kidney function rather than iron itself.

These studies assessed relationships at one point in time. They cannot show whether urinary iron influenced the conditions or whether other differences explain the findings. They also don't establish that low urinary iron reflects inadequate intake or depleted body stores. Different populations and outcomes have produced different associations, so there is no established universally favorable direction for this result.

Iron Overload

Repeated transfusions and hereditary hemochromatosis can cause iron to accumulate in the body. Urinary iron can increase with systemic overload even when the kidneys work normally, but it is not a reliable stand-alone measure of the burden. Blood iron studies are the starting point. Suspected hemochromatosis is followed up with HFE genetic testing and sometimes liver imaging; transfusion-related overload is tracked with ferritin and MRI of liver and heart iron.

During chelation, urinary iron is a supporting measure, not the main one. It reflects the drug's work only for deferoxamine and deferiprone. Deferoxamine sends roughly 60% of the iron it removes into urine and 40% into stool, while deferiprone sends most of it into urine. Deferasirox, the most widely used chelator, clears about 90% of its iron through stool, so urinary iron says little about how well it's working.

When Results Can Be Misleading

• Urine concentration: fluid intake changes a spot concentration. Expressing iron relative to urine creatinine can partly account for dilution, but a concentration, a creatinine-adjusted result, and a daily excretion total are different measurements. In one study, spot and 24-hour results tracked each other poorly.
• Creatinine adjustment: women and older or undernourished people make less creatinine, so their iron-to-creatinine ratios can look higher even when their daily iron loss is lower.
• Blood in the sample: menstrual contamination or bleeding within the urinary tract can contribute iron. This can obscure the reason for an increased result, and urinary bleeding may itself need investigation.
• Supplements and treatment: oral iron use was associated with higher urinary iron in transplant recipients. Deferoxamine and deferiprone increase urinary iron through their intended action; deferasirox clears iron mainly through stool and barely changes it.
• Smoking: in a study of 38 professional welders and 36 unexposed workers, smoking predicted urinary iron more strongly than welding exposure did.
• External contamination: collection containers, dust, or metal contact can introduce iron into a sample. Trace-metal collection materials reduce this risk.
• Chemical form: total iron measurement does not distinguish iron carried by proteins from iron bound to a treatment drug or present in blood. A higher total does not identify how much is capable of damaging tissue.

Vigorous exercise, urinary infection, and urinary tract injury can cause blood in urine. Their presence changes the interpretation of an iron result; they should not automatically be treated as evidence of chronic iron overload or kidney damage.

What a Trend Can Show

A repeated-sampling study in healthy men found that single spot samples reproduced poorly for urinary iron across days and months; at least three samples were needed to classify a person reasonably. Repeated measurements can help distinguish a persistent finding from sampling variation. They have not established an optimal personal level, a meaningful change threshold, or a proven strategy for preventing disease.